Feder Julie B
SEC CIK 1710237 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | CFO | 134.3K | — | $448.1K | 10 | 2021-10-28 | 2024-10-18 |
Most active insiders at AURA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Matrix Capital Management Company, LP | 10% | — | $39.04M |
| 2 | de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| 3 | Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| 4 | Plavsic Mark | CTO | — | $157.5K |
| 5 | Kilroy Conor | See Remarks | — | $143.4K |
| 6 | Gibney Anthony S | See Remarks | — | $82.3K |
| 7 | Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| 8 | Kratz Erica | Chief Reg, Quality Off | — | — |
| 9 | Abu-Absi Susan | COO | — | — |
| 10 | Bitetti Teresa Marie | Dir | — | — |
Feder Julie B made no open-market trades at AURA in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-10-21 | 2024-10-18 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | S - Sale+OE | $12.03 | -25.1K | 134.3K | -16% | -$302.3K |
| DMT | 2024-10-21 | 2024-10-18 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | M - OptEx | $3.44 | +25.1K | 159.4K | +19% | +$86.5K |
| D | 2024-02-02 | 2024-02-01 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | A - Grant | $0.00 | +71.3K | 134.3K | +113% | $0 |
| 2024-01-24 | 2024-01-23 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | S - Sale | $7.64 | -6,609 | 63.0K | -9% | -$50.5K | |
| DT | 2023-11-07 | 2023-11-06 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | S - Sale+OE | $12.07 | -3,900 | 69.6K | -5% | -$47.1K |
| DT | 2023-11-07 | 2023-11-06 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | M - OptEx | $2.74 | +3,900 | 73.5K | +6% | +$10.7K |
| 2023-11-01 | 2023-10-30 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | S - Sale | $6.82 | -3,385 | 69.6K | -5% | -$23.1K | |
| D | 2023-01-23 | 2023-01-19 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | A - Grant | $0.00 | +48.8K | 73.0K | +201% | $0 |
| 2022-11-02 | 2022-10-31 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | S - Sale | $12.45 | -2,015 | 24.2K | -8% | -$25.1K | |
| D | 2021-10-29 | 2021-10-28 | AURA | Aura Biosciences, Inc. | Feder Julie B | CFO | A - Grant | $0.00 | +26.2K | 26.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations